ANTHELMINTIC ACTIVITY OF METHYRIDINE AGAINST EXPERIMENTAL NEMATODE INFECTIONS IN MICE

Similar documents
SUMMARY OF PRODUCT CHARACTERISTICS

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: REPRODUCTION TESTING

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SUMMARY of PRODUCT CHARACTERISTICS

THE VETERINARIAN'S CHOICE. Compendium clinical Trials. Introducing new MILPRO. from Virbac. Go pro. Go MILPRO..

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

CAZITEL FLAVORED ALLWORMER FOR DOGS

ALBENDAZOLE AND ITS ANALOGUES

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

INTERNAL PARASITES (MOST IMPORTANT HELMINTHS)

Effects of Late-Summer Protein Supplementation and Deworming on Performance of Beef Calves Grazing Native Range

Summary of Product Characteristics

Summary of Product Characteristics

EFFICACY OF ANTHELMINTICS: SPECIFIC RECOMMENDATIONS FOR PORCINES

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

HOOKWORM FAQ SHEET (rev ) Adapted from the CDC Fact Sheet

Horse Owner s Guide To Worming

European public MRL assessment report (EPMAR)

SUMMARY of PRODUCT CHARACTERISTICS (SPC)

Tablet. A light-brown to brown, meat flavoured, bone shaped tablet scored on both sides that can be divided into halves.

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

MARBOCYL FD SUMMARY OF PRODUCT CHARACTERISTICS

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Summary of Product Characteristics

[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Please refer to Table 1 Dosage and Treatment Schedule TABLE 1 Species Product Number of Tubes Cats. Rabbits or Advantage 40 for Cats

Parasites in Sheep Flocks

The current state of anthelmintic resistance in the UK and simple messages to slow the progression

MOXIDECTIN SPOT-ON SOLUTION FOR KITTENS AND SMALL CATS. 280 mg/ml FLURALANER 14 mg/ml MOXIDECTIN Also contains: 339 mg/ml DIMETHYLACETAMIDE (solvent)

Journal of Chemical and Pharmaceutical Research

Efficacy of Moxidectin 6-Month Injectable and Milbemycin Oxime/Lufenuron Tablets Against Naturally Acquired Toxocara canis Infections in Dogs*

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS (Reference Member State) MUTUAL RECOGNITION PROCEDURE

submitted in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE KANSAS STATE COLLEGE

EC Cattle Grub Control in Nebraska

European Public MRL assessment report (EPMAR)

Metacam 1.5 mg/ml oral suspension for dogs

HEARTWORM DISEASE AND THE DAMAGE DONE

Characterization of Haemonchus contortus

SUMMARY OF PRODUCT CHARACTERISTICS

What causes heartworm disease?

Demodex in Puppies. Demodectic mange looks like hair loss in small dime to quarter shapes on the face and forelegs.

MATERIAL SAFETY DATA SHEET

Horse Owner s Guide To Worming

DEPOSEL Slow Release Selenium Injection for Cattle and Sheep

SUMMARY OF PRODUCT CHARACTERISTICS

Administering wormers (anthelmintics) effectively

Poultry Drugs. Amoxicillin W.S.P 20% W.S.Powder 1. Amoxicillin W.S.P 50% W.S.Powder 2. Cotusin-666 W.S.Powder 3. Doxin-200 W.S.

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

Effects of an Ivermectin Otic Suspension on Egg Hatching of the Cat Ear Mite, Otodectes cynotis, in Vitro*

Author - Dr. Josie Traub-Dargatz

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

Nematodes 2. Lecture topics. Ascarid life cycle. Main features of the Ascarids. Adults L 5 L 1 L 4 L 2 L 3. Groups that you need to know about

Anthelmintic resistance in beef cattle what are the levels and what can be done to lessen its impact?

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SUMMARY OF PRODUCTS CHARACTERISTICS

Nematodes 2. BVM&S Parasitology T.W.Jones

Summary of Product Characteristics

Cydectin. Fort Dodge PRODUCT DESCRIPTION

Efficacies of fenbendazole and albendazole in the treatment of commercial turkeys artificially infected with Ascaridia dissimilis

Health Products Regulatory Authority

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Daniel Kulke 1,2,Jürgen Krücken 1 *, Achim Harder 3, Georg von Samson-Himmelstjerna 1. Abstract. Introduction

HUSK, LUNGWORMS AND CATTLE

My fish appear to be itchy... they re jumping about, scraping and flicking

Summary of Product Characteristics

Recommended for Implementation at Step 7 of the VICH Process on 21 November 2000 by the VICH Steering Committee

ESTRUS SYNCHRONIZATION AND CALVING EASE AMONG FIRST CALF HEIFERS. D.G. Landblom and J.L. Nelson

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary

LAMB GROWTH AND EWE PRODUCTION FOLLOWING ANTHELMINTIC DRENCHING BEFORE AND AFTER LAMBING

SHE SINGS ALONG TO EVERY SONG...

Diagnosis, treatment and control: dealing with coccidiosis in cattle

SUMMARY OF PRODUCT CHARACTERISTICS

Material Safety Data Sheet

SUMMARY OF PRODUCT CHARACTERISTICS

Internal parasites in beef cattle. SBIC 2017 Fabienne Uehlinger

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Tautopathic Treatment. Systemic infection or localized infections

Anolyte Application in Pig Farming

Anthelmintics in Pigs

Comparison of Lufenuron and Nitenpyram Versus Imidacloprid for Integrated Flea Control*

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Clozanox 150. Closantel Oral Solution. Protect your live stock with. COMPOSITION: Each ml contains: Closantel 150 mg

SUMMARY OF THE PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

A NATURAL HEARTWORM SOLUTION

INVIVO STUDY ON THE EFFICACY OF Vernonia amygdalina (BITTER LEAF) EXTRACT ON Ascaris lumbricoides, USING MICE

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Determination of the Anthelmintic Efficacy of Albendazole in the Treatment of Chickens Naturally Infected with Gastrointestinal Helminths

Example 1: Quality Assurance Individual

Importance of Frequency Homeopathic application

SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

Brit. J. Pharmaeol. (1961), 17, 321-326. ANTHELMINTIC ACTIVITY OF METHYRIDINE AGAINST EXPERIMENTAL NEMATODE INFECTIONS IN MICE BY A. W. J. BROOME AND N. GREENHALGH From Imperial Chemical Industries, Pharmaceuticals Division, Research Department, Alderley Park, Macclesfield, Cheshire (Received May 3, 1961) Critical studies using mice infected experimentally with nematodes (Nematospiroides dubius, Nippostrongylus muris and Heterakis spumosa) have shown methyridine to be an extremely effective anthelmintic when administered orally or subcutaneously. Comparisons of the two treatment regimes show subcutaneous administration to be the more efficient in terms of absolute dose, but neither treatment has a significant advantage in therapeutic safety margin. Methyridine has a more uniform anthelmintic action than either phenothiaine or bephenium against adult forms of the three test nematodes. In addition the drug possesses activity against all stages of certain immature nematode infections. Although certain pyridine alkaloids possess anthelmintic properties, no simple pyridine derivative had shown useful activity until the recent paper of Broome & Greenhalgh (1961) describing the effects of 2-(/-methoxyethyl)pyridine (methyridine) )CH2 CH2OCH3 I (I) (active principle of "Promintic," Imperial Chemical Industries). It was shown that methyridine has considerable anthelmintic activity against experimental nematode infections of mice. Methyridine may be prepared by a method similar to that used for the corresponding ethyl homologue by Doering & Weil (1947). It is a colourless, sweet-smelling liquid (b.p. =94 to 96 C/ 17 mm, sp. gr.2 =.988, n2 = 1.4975) and is completely miscible with water and common solvents in all proportions. In addition the compound is a weak base (pk. approximately 5.5) which forms a water-soluble hydrochloride (m.p. 14 to 15 C), hydrobromide (m.p. 84 to 86 C) and picrate (m.p. 13 to 131 C). In the present paper detailed anthelmintic studies with nematode infections of mice are described, including comparative tests with other anthelmintics and some toxicological work.

322 A. W. J. BROOME and N. GREENHALGH METHODS Nematodes. All tests were carried out using one or more of the three nematodes Heterakis spumosa, Nippostrongylus muris and Nematospiroides dubius. Cultures of H. spumosa and N. muris were maintained in rats by the methods of Smith (1953) and Brackett & Blinick (1949) respectively. N. dubius was cultured in exactly the same way as N. muris except that mice, instead of rats, were used as host animals and they were infected orally. Trials with adult nematode infections in mice. The methods used for these trials were essentially those developed earlier in these laboratories by Dr D. G. Davey. They have not previously been described and a full account of them is therefore included. To conserve animals, time and materials, each mouse received two nematode infections consisting of H. spumosa in the large intestine and either N. muris or N. dubius in the small intestine. Care was taken to ensure that all species reached maturity together so that none were being naturally eliminated at the time of the trial. This was achieved by infecting newly weaned mice (13 to 15 g and reared under pathogen-free conditions) with 35 embryonated H. spumosa eggs given orally 28 days before the experiment was due to commence. Sixteen days later half the mice were infected with 1 N. dubius larvae orally and seven days before the commencement of the experiment the remaining mice received 5 N. muris larvae together with 1.25 mg cortisone acetate (both given subcutaneously). Thus at the commencement of the experiment the infections of H. spumosa were 28 days old, those of N. dubius 12 days old and N. muris 7 days old, and all were at the early adult stage. Experimental design. Three separate balanced factoral experiments involving over 8 mice were used to compare the anthelmintic activity of methyridine (oral and subcutaneous injection), bephenium (a mixture of 33% bephenium embonate+67% bephenium hydroxynaphthoate) and fine-particle phenothiaine. The first two trials were needed to compare the dose/parasite mortality relationships of the three drugs, using doses graded from those having no activity against the parasite to those producing toxic effects in the host. The third experiment was concerned solely with providing additional information on the relative activity of methyridine when administered orally and subcutaneously. Groups of 1 mice (all infected with H. spumosa but 5 containing N. muris and 5 N. dubius in addition) were randomly assigned to each dosage regime. A similar group of 1 mice served as control in each experiment to provide an estimate of the worm burden before treatment. Administration of drugs. All drugs were administered in a single dose to provide information on the type of activity likely to be achieved under practical conditions in the field. The appropriate dose of drug was prepared in.5 ml. of a dispersing agent for those animals dosed orally but in.2 ml. for the subcutaneous treatments. The dispersing agent contained.1% Lissapol C,.1% Lissapol N.X. and.1% Dispersol O.G. All treatments were administered on Day I of the experiment. Assessment of anthelmintic activity. Anthelmintic activity was assessed by comparing the worm burdens of treated and control animals at post-mortem examination 5 days after treatment. To facilitate worm-counting the animals were starved 24 hr prior to sacrifice. After killing, the abdomen was opened and the large and small intestines were removed to separate petri-dishes. Each large intestine was slit longitudinally, and all H. spumosa worms were scraped into warm water. They were then transferred to a transparent container (with transverse lines to facilitate counting) and counted over a black tile. The small intestines containing N. muris were compressed between perspex plates and the nematodes were counted with the aid of an illuminated magnifying-glass over a white tile. To assess the number of N. dubius it was necessary to slit the upper part of the small intestine and to scrape the worms into warm water. They were then gently teased apart and counted in a transparent dish over a white tile. Trials with immature nematode infections of mice. These trials were confined to the relatively rapid maturing nematodes N. muris and N. dubius. Equal numbers of clean mice were infected with either N. muris or N. dubius larvae, using the techniques previously

ANTHELMINTICS IN MICE 323 described. A single experiment involving about 25 mice was used to investigate the anthelmintic activity of graded doses of methyridine (subcutaneous injection) and bephenium (oral) against 1-, 2-, 4-, 6- and 8-day-old infections respectively. Groups of 1 mice (5 infected with N. muris and 5 with N. dubius) were randomly assigned to each treatment and 1 similar mice served as controls. All drugs were administered as previously described, and anthelmintic activity was assessed by worm counts made at post-mortem examination 12 days after infection. Acute toxicity. The standard technique for estimating acute drug toxicity has been used in these experiments. At least 5 groups of 1 mice (of the same weight and infected with nematodes as in the anthelmintic tests) were used to assess the toxicity of graded doses of the three anthelmintic drugs. Statistical techniques. All statistical analyses have been kindly carried out by our colleague Dr. L. Davies, using the probit mortality/log dose relationship to assess the toxicity of these drugs to parasites and hosts. RESULTS The relative efficiency of methyridine, bephenium and phenothiaine against adult nematode infections in mice. The results of anthelmintic and toxicity trials are presented in Table 1 together with two indices of chemotherapeutic efficiency. These are based on the ratio between doses of drug killing 5% of the hosts and 5% of the parasites (LD5/ED5; Table la) and those killing 5% of the hosts and 95% of the parasites (LD5/ED95; Table lb). Of the drugs tested, only methyridine possessed useful anthelmintic activity when administered by subcutaneous injection. Any given dose of the drug was significantly more effective when given subcutaneously than orally (Table 1). Whether injected subcutaneously or administered orally, methyridine was a more efficient anthelmintic than either bephenium or phenothiaine in terms of absolute dose. Since there are large differences in the relative toxicity of these three anthelmintic drugs it is necessary to compare the therapeutic ratios to evaluate their comparative merit. The data presented in Table 1 indicate that the therapeutic ratios for treating parasitied mice with methyridine are similar for all three test nematodes. By contrast, the other drugs vary widely in their effectiveness against the same test organisms. As a result methyridine is the only drug among those tested which will almost completely eliminate all test infections at a safe therapeutic dose. The anthelmintic activity of methyridine and bephenium against immature nematode infections of mice. The results of these studies indicate that subcutaneously administered methyridine possesses marked anthelmintic activity against certain immature nematode infections of mice. Comparisons with bephenium show methyridine to be the more active drug in terms of absolute dose. Thus the ratios for doses of methyridine and bephenium needed to produce approximately the same degree of anthelmintic activity were 1/3.2 (N. muris) and 1/4. (N. dubius) respectively. This compares with the corresponding ratios of 1/1.3 and 1/6.3 for the adult forms of these nematodes (Table la). The anthelmintic activity of the two drugs administered in doses of equal toxicity to the host (approximately 5% of LD5) is shown in Fig. 1. The results obtained from the previous experiment with 12-day-old N. dubius infections have been included for completeness.

:s O cs ~ 324 A. W. J. BROOME anad N. GREENHALGH I'l SO~ I o 4.) p]e = I -11 :, -,go r *E 41 H - - E.= I con en m C14 "\\X.Ol 9. K~o ~1 -. ", i!4-14 4 tn C:m A.: u w to co iw 4n tn I'l 11I t,, a. I9. u2o.i-c4 -.14 113.1 li11 \ ub I." 4 r- q -H -H L _e C1 ONi o O1N tn a -f 1 $4 gz rt In - -H -H +H onni _E CZ :.Cm.,N in ",I tn in "ot 6 *: :. :. & \o \ v.9 -H -H -f-h =~~~~~~t F m~~~% >,, 'a.-* in tn U. Pt-4 x.4 g F-I I.-I H -HH "D Wo t 4ene.o H -H H- WI enwi W _!. eq d- _ r4 el la --N bo a S" 8 la -S 5 1 :3 1. = -4. -S.,.8 t 5 %-., :. 4

ANTHELMINTICS IN MICE 325 99.5 99 98 97 95 9g- N. muris X 4. -6 E io.c, 8 I 7 6 5 4 3 2 97 95 9 _ I Adults 3rd stage 4th stage 5th stage in lung I in intestine Iin lumen lof intestine N. dubius 8 7 6 5 4 A" 3 Adults 3rd stage 4th stage 5th Istage lu I - - _... I I in lumen in muscle of intestine In lumen of intestine - - I a a 1 1 a a 1 2 3 4 5 6 7 8 9 1 11 Age of infection at time of treatment (days) Fig. 1. Effect of methyridine subcutaneously and bephenium (oral) on immature nematode infections in mice. * methyridine (1 mg/25 g). * - -- bephenium (32 mg/25 g). Fig. 1 shows that methyridine tends to give slightly better results than the equivalent dose in terms of toxicity of bephenium against immature N. muris, particularly when administered soon after infection. In addition, methyridine appears clearly more efficient than bephenium against immature N. dubius of all ages. However, these conclusions can only be regarded as indications when the standard errors attached to the toxicity data (Table lb) are considered. II 12

326 A. W. J. BROOME and N. GREENHALGH DISCUSSION The anthelmintic studies described in this report indicate clearly that methyridine possesses considerable activity against both adult and immature nematode infections of mice. Examination of the results shows the drug is generally more active against adult worms than either phenothiaine or bephenium, two of the anthelmintics most commonly employed in veterinary practice. The margin of safety between toxic and therapeutic doses of methyridine is not so great as that for the other drugs when considered in relation to selected individual nematode species. However, considering the three test nematodes as representing a mixed natural infection, methyridine is the only compound (of those tested) which will almost completely cure mice at a safe therapeutic dose. It is this uniformity of action against the three nematode species examined, irrespective of their habitat or location in the alimentary canal, which makes the drug unique in our experience. Another interesting feature associated with the anthelmintic action of methyridine is the fact that it is more effective in terms of absolute dose when administered subcutaneously than when administered orally. However, it is also more toxic by subcutaneous injection, so that there is little to choose between the two methods of treatment on the grounds of safety. In addition to possessing activity against adult nematodes, a good anthelmintic must also be active against the immature forms. The comparative trials indicate that methyridine is at least as good as bephenium against immature nematode infections. It appears that differences in the relative activity of the two drugs against adult worms are reflected in their relative activity against the corresponding immature forms. However, certain exceptions do arise, as illustrated by the trials with 1- and 2-day-old N. muris infections; here methyridine appears to be clearly the more effective drug, and it should be noted that the larvae of N. muris are actually migrating through the lung at this time. Thus methyridine is able to affect nematode larvae which are not even in the gut. This feature is unlikely to be shared by any of the conventional relatively insoluble anthelmintics which are poorly absorbed by the mammalian host. The authors are pleased to acknowledge their gratitude to Miss R. M. Potts and Mrs J. Parkinson for their able technical assistance with these studies. REFERENCES BRACKErr, S. & BLIZNICK, A. (1949). Screening large numbers of new chemical compounds for anthelmintic activity using infections with Nippostrongylus muris in mice. J. Parasitol., 35, 8-18. BROOME, A. W. J. & GREENHALGH, N. (1961). A new anthelmintic with unusual properties. Nature, Lond., 189, 59-6. DOERNG, W. E. & WEIL, R. A. N. (1947). Electrophilic reactions of 2- and 4-vinylpyridines. J. Amer. chem. Soc., 69, 2461-2466. SMITH, P. E. (1953). Life history and host-parasite relations of Heterakis spumosa, a nematode parasite in the colon of the rat. Amer. J. Hyg., 57, 194-221.